July 14, 2011 -- Guizhou Bailing Group Pharmaceutical paid 40 million RMB ($6.2 million) for a 60% stake in Guizhou Herentang Pharmaceutical, a company with six patents for Miao ethnic TCMs. Both Herentang and Bailing specialize in TCMs that are part of the minority Miou culture of Southern China. Herentang also produces pediatric paracetamol and amantadine hydrochloride. More details....
Stock Symbol: (SHE: 002424)
